Dr. Fliegelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13755 Cicero Ave
Crestwood, IL 60418Phone+1 888-220-6432Fax+1 630-654-4253
Education & Training
Rush University Medical CenterFellowship, Infectious Disease, 1982 - 1984
Philadelphia College of Osteopathic MedicineClass of 1979
Certifications & Licensure
IL State License 1980 - 2026
NE State License 2019 - 2026
AZ State License 2019 - 2026
MI State License 2012 - 2025
WI State License 2019 - 2025
WA State License 2019 - 2025
TN State License 2019 - 2025- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 16 citationsTocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise, Robert M. Fliegelman, Jonathan Pinsky
Clinical and Translational Science. 2021-11-01 - 10 citationsEarly Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin, Robert M. Fliegelman, Vishnu Chundi
Critical Care Explorations. 2021-03-29 - 14 citationsA Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline.Nicholas W. Van Hise, Russell M. Petrak, Nathan C. Skorodin, Robert M. Fliegelman, Michael Anderson
Infectious Diseases and Therapy. 2020-10-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
